5 Results for "

CDK7-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "CDK7-IN-2" in MCE Product Catalog:

Cat. No.: HY-161830
CAS No.: 2603381-71-9
Research Areas:  

Cancer

CDK7 ligand 2 (Compound A6) is a CDK7 ligand. CDK7 ligand 2 can be used in the synthesis of PROTACs .
loading...
    loading...
Cat. No.: HY-136711
CAS No.: 2326428-24-2
Target:  

CDK

Research Areas:  

Cancer

CDK7-IN-2 hydrochloride hydrate (Example 6) is a potent and selective CDK7 inhibitor. CDK7-IN-2 has potent anti-cancer activity .
loading...
    loading...
Cat. No.: HY-143587
CAS No.: 2326428-19-5
Purity:  98.93%
Target:  

CDK

Research Areas:  

Cancer

CDK7-IN-2 is a potent inhibitor of CDK7. CDK7 is implicated in both temporal control of the cell cycle and transcriptional activity. CDK7 is implicated in the transcriptional initiation process by phosphorylation of Rbpl subunit of RNA Polymerase II (RNAPII). CDK7 has the potential for the research of cancer disease, in particular aggressive and hard- to-treat cancers (extracted from patent WO2019099298A1, compound 1) .
loading...
    loading...
Cat. No.: HY-161829
Research Areas:  

Cancer

CDK7 ligand 1 is an active control ligand for CDK7 ligand 2 (HY-161830). CDK7 ligand 2 is a CDK7 ligand. CDK7 ligand 2 can be used in the synthesis of PROTACs .
loading...
    loading...
Cat. No.: HY-162619
Target:  

Apoptosis CDK

Research Areas:  

Cancer

CDK9-IN-33 (compound C35) is a potent, selective and orally active CDK9 inhibitor with IC50 values of 17.44, 160, 316.30, 1771.00, >10000 nM for CDK9, CDK7, CDK2, CDK4, CDK6 respectively. CDK9-IN-33 induces apoptosis. CDK9-IN-33 decreases the protein expression of RPB1 CTD Ser2, RPB1, MCL1. CDK9-IN-33 shows anti-tumor activity .
loading...
    loading...